Although wearables have yet to establish themselves as a mainstream clinical trial technology, some research teams are already looking to the next big thing: implantables. Pierre Fabre has moved itself to the front of the field by striking a deal to test a chip in a schizophrenia development program. (FierceBiotechIT)